Document is current
Any future updates will be listed below
-
Authors
Böff, Lena
Bartz, Antonia
Harries, Manuela
,
Strengert, Monika
Dulovic, Alex
Schneiderhan-Marra, Nicole
Castell, Stefanie
Heise, Jana-Kristin
Klett-Tammen, Carolina
Krause, Gérard
Hernandez, Pilar
Gornyk, Daniela
Schlüter, Monike
Kerrines, Tobias
Bojara, Gerhard
Frank, Kerstin
Gubbe, Knut
Tonn, Torsten
Kappert, Oliver
Kern, Winfried V.
Illig, Thomas
Klopp, Norman
Roller, Gottfried
Ziemons, Michael
,
Berger, Tom
Chaturvedi, Madhav
Jarvis, Christopher I.
Rübsamen, Nicole
Scholz, Stefan
Walde, Jasmin
,
Bardeck, Nils
Bock, Wolfgang
Boehm, Michael
Böhler, Laura-Inés
Bracher, Johannes
Contreras, Sebastian
Denkinger, Claudia
Dönges, Philipp
Gottschick, Cornelia
Guenther, Felix
Heinsohn, Torben
Hovardovska, Olga
Junker, Daniel
Kaiser, Rolf
Koeppel, Lisa
Krueger, Tyll
Kuhlmann, Alexander
Marsall, Patrick
Priesemann, Viola
Reinacher, Ulrich
Rodiah, Isti
Schienle, Melanie
Wolffram, Daniel
Karch, André
Aigner, Annette
Jaeger, Veronika K.
Lange, Berit
-
Funding
Funding for this research was provided by:
Institute of Epidemiology and Social Medicine, University of Münster
Bundesministerium für Bildung und Forschung (01KX2121)
Bundesministerium für Bildung und Forschung (01KX2121)
Bundesministerium für Bildung und Forschung (01KX2021)
Bundesministerium für Bildung und Forschung (MV2021-012)
Bundesministerium für Bildung und Forschung (01KX2121)
Bundesministerium für Bildung und Forschung (01KX2021)
Bundesministerium für Bildung und Forschung (01KX2121)
Helmholtz Zentrum für Infektionsforschung, Germany
Helmholtz Association (SO-096HZEPiAdHoc & LOKI: KA1-Co-08)
Helmholtz Association (SO-096HZEPiAdHoc & LOKI: KA1-Co-08)
European Union's Horizon 2020 research and innovation program (101003480; 10107382; 101095606)
European Union's Horizon 2020 research and innovation program (101003480; 10107382; 101095606)
German federal states
Institute of Medical Epidemiology, Biometry and Informatics, Martin Luther University Halle-Wittenberg
Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.
Saxonian COVID-19 Research Consortium SaxoCOV
Deutsche Forschungsgemeinschaft (458526380)
Deutsche Forschungsgemeinschaft (458526380)
Deutsche Forschungsgemeinschaft (458526380)
Robert Koch Institut
Universität Münster
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 11 June 2025
First Online: 7 July 2025
Declarations
:
: Primary data of the MuSPAD study were recorded for research purposes. The study was approved by the Ethics Committee of the Hannover Medical School on 21.6.2020 prior to the implementation of the survey phase, taking into account data security issues in accordance with the EU General Data Protection Regulation (GDPR) (granted ethics vote number “9086_BO_S_2020”). At the time of enrolment, written consent was obtained from the study participants after detailed information and explanation of the scope and objectives of the study, before the actual data and sample collection took place.The responsible ethics committees for NAKO (Bavarian Medical Association “Bayerische Landesärztekammer” [13023, 13031] and Medical Association of Lower Saxony “Ärztekammer Niedersachen” [Grae/067/2013]) approved all NAKO-related human examinations.COVIMOD was approved by the ethics committee of the Medical Board Westfalen-Lippe and the University of Münster, reference number 2020-473-f-s. Informed consent was obtained from all COVIMOD participants.
: Not applicable.
: The authors declare the following competing interests: Stefan Scholz (COVIMOD Consortium Group member) is currently an employee of Moderna Germany GmbH, Munich, Germany.The other authors declare that they have no competing interests.
